| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.6058 | 
      | Human Intestinal Absorption | HIA+ | 0.5202 | 
      | Caco-2 Permeability | Caco2- | 0.9214 | 
      | P-glycoprotein Substrate | Substrate | 0.6087 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8815 | 
                                                     | Non-inhibitor | 0.9110 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8724 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5362 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8139 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8874 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6124 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9414 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9327 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9119 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9207 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8472 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9689 | 
                                                                    | Non-inhibitor | 0.7263 | 
      | AMES Toxicity | AMES toxic | 0.8296 | 
      | Carcinogens | Non-carcinogens | 0.9687 | 
      | Fish Toxicity | High FHMT | 0.7211 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9332 | 
      | Honey Bee Toxicity | High HBT | 0.6646 | 
      | Biodegradation | Ready biodegradable | 0.5469 | 
      | Acute Oral Toxicity | III | 0.4513 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7090 |